| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABC2 – Disclosure of Conflict of Interest
|
|
|
2013
|
22 |
S3 |
p. S65-S66
2 p.
|
artikel
|
| 2 |
Abstract Presenters
|
|
|
2013
|
22 |
S3 |
p. S15-S16
2 p.
|
artikel
|
| 3 |
Abstracts List
|
|
|
2013
|
22 |
S3 |
p. S71-S73
3 p.
|
artikel
|
| 4 |
Authors index
|
|
|
2013
|
22 |
S3 |
p. S67-S70
4 p.
|
artikel
|
| 5 |
Award, Chairs and Panel Members
|
|
|
2013
|
22 |
S3 |
p. S8-
1 p.
|
artikel
|
| 6 |
BP27 COUNT US, KNOW US, JOIN US GLOBAL SURVEY: LOOKING AT QUALITY OF LIFE ISSUES AFFECTING ADVANCED BREAST CANCER PATIENTS WORLDWIDE AND THE ROLE OF THEIR CAREGIVERS
|
Mertz, Shirley
|
|
2013
|
22 |
S3 |
p. S27-S28
2 p.
|
artikel
|
| 7 |
BP41 EFFECTIVENESS OF TAXANE- OR ANTHRACYLINE-BASED COMPARED TO TAXANE- AND ANTHRACYLINE-FREE FIRST-LINE TREATMENTS OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS. DATA FROM THE TMK REGISTRY GROUP
|
Marschner, Norbert
|
|
2013
|
22 |
S3 |
p. S33-
1 p.
|
artikel
|
| 8 |
BP40 MULTICENTER PHASE II STUDY OF APATINIB, A NOVEL INHIBITOR OF VEGFR, IN HEAVILY PRETREATED PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER
|
Hu, Xi-chun
|
|
2013
|
22 |
S3 |
p. S33-
1 p.
|
artikel
|
| 9 |
Breast Cancer Patient Advocacy Programme
|
|
|
2013
|
22 |
S3 |
p. S10-
1 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2013
|
22 |
S3 |
p. i-
1 p.
|
artikel
|
| 11 |
Endorsement and Auspices
|
|
|
2013
|
22 |
S3 |
p. S4-
1 p.
|
artikel
|
| 12 |
ESO Advanced Breast Cancer Task Force
|
|
|
2013
|
22 |
S3 |
p. S9-
1 p.
|
artikel
|
| 13 |
General Information
|
|
|
2013
|
22 |
S3 |
p. S2-S3
2 p.
|
artikel
|
| 14 |
IN1 ABC2 AWARD ABSTRACT: ORIGINS OF METASTATIC TRAITS
|
Massagué, Joan
|
|
2013
|
22 |
S3 |
p. S19-
1 p.
|
artikel
|
| 15 |
IN4 ADVANCES IN ADVANCED TRIPLE NEGATIVE BREAST CANCER
|
Sledge, George W.
|
|
2013
|
22 |
S3 |
p. S19-
1 p.
|
artikel
|
| 16 |
IN6 ADVANCES IN CYTOTOXIC AND OTHER TARGETED THERAPY OUT OF HER2, ER AND TRIPLE NEGATIVE METASTATIC BREAST CANCERS
|
Gligorov, Joseph
|
|
2013
|
22 |
S3 |
p. S20-
1 p.
|
artikel
|
| 17 |
IN5 ADVANCES IN ENDOCRINE THERAPY AND ENDOCRINE RESISTANCE
|
Pinto, Ana Catarina
|
|
2013
|
22 |
S3 |
p. S19-S20
2 p.
|
artikel
|
| 18 |
IN7 ADVANCES IN MR IMAGING
|
Padhani, Anwar R.
|
|
2013
|
22 |
S3 |
p. S20-
1 p.
|
artikel
|
| 19 |
IN2 A PERSONAL JOURNAL THROUGH ADVANCED BREAST CANCER
|
Fenech, Doris
|
|
2013
|
22 |
S3 |
p. S19-
1 p.
|
artikel
|
| 20 |
IN14 BRCA-RELATED ADVANCED BREAST CANCER
|
Francis, Prudence A.
|
|
2013
|
22 |
S3 |
p. S23-
1 p.
|
artikel
|
| 21 |
IN19 CAN SPECIFIC SITES OF METASTASES BE PREDICTED AND PREVENTED?
|
Veer, Laura van't
|
|
2013
|
22 |
S3 |
p. S24-
1 p.
|
artikel
|
| 22 |
IN18 CHEST WALL RECURRENCES AND CUTANEOUS METASTASIS
|
Blackwell, Kimberly L.
|
|
2013
|
22 |
S3 |
p. S24-
1 p.
|
artikel
|
| 23 |
IN25 DISPARITIES IN ACCESS TO SUPPORTIVE/PALLIATIVE SPECIALIZED CARE
|
El Saghir, Nagi S.
|
|
2013
|
22 |
S3 |
p. S27-
1 p.
|
artikel
|
| 24 |
IN20 FROM SINGLE CELL MOTILITY TO SIGNALLING AND METABOLIC INTEGRATION: HOW MATHEMATICAL AND PHYSICAL MODELS CAN HELP CONTROL METASTASES IN PERSONALIZED MEDICINE
|
Wynn, Michelle
|
|
2013
|
22 |
S3 |
p. S24-S25
2 p.
|
artikel
|
| 25 |
IN12 INOPERABLE LOCALLY ADVANCED BREAST CANCER: SURGERY – CHALLENGES AND OPPORTUNITIES
|
Cardoso, M.J.
|
|
2013
|
22 |
S3 |
p. S22-
1 p.
|
artikel
|
| 26 |
IN9 LOCALLY ADVANCED BREAST CANCER – EPIDEMIOLOGY AND GEOGRAPHIC DIFFERENCES
|
Senkus, Elżbieta
|
|
2013
|
22 |
S3 |
p. S21-
1 p.
|
artikel
|
| 27 |
IN13 METASTATIC MALE BREAST CANCER
|
Giordano, Sharon H.
|
|
2013
|
22 |
S3 |
p. S23-
1 p.
|
artikel
|
| 28 |
IN15 MULTIDISCIPLINARY APPROACH TO LIVER METASTASIS IN BREAST CANCER
|
Barrios, Carlos H.
|
|
2013
|
22 |
S3 |
p. S23-S24
2 p.
|
artikel
|
| 29 |
IN22 OPTIMAL MANAGEMENT OF NAUSEA AND VOMITING
|
Bergh, Jonas
|
|
2013
|
22 |
S3 |
p. S25-S26
2 p.
|
artikel
|
| 30 |
IN21 OPTIMAL PAIN MANAGEMENT
|
Biganzoli, Laura
|
|
2013
|
22 |
S3 |
p. S25-
1 p.
|
artikel
|
| 31 |
IN24 PATIENT PERSPECTIVES ON SYMPTOM CONTROL
|
Mayer, Musa
|
|
2013
|
22 |
S3 |
p. S26-S27
2 p.
|
artikel
|
| 32 |
IN23 PSYCHOLOGICAL SUPPORT: WHEN AND HOW
|
Fallowfield, Lesley
|
|
2013
|
22 |
S3 |
p. S26-
1 p.
|
artikel
|
| 33 |
IN11 RADIOTHERAPY: BEST TIMING AND TECHNIQUES
|
Vrieling, Conny
|
|
2013
|
22 |
S3 |
p. S21-S22
2 p.
|
artikel
|
| 34 |
IN10 SYSTEMIC THERAPY FOR INOPERABLE LOCALLY ADVANCED BREAST CANCER: OPTIMAL STRATEGIES AND THERAPIES
|
Harbeck, Nadia
|
|
2013
|
22 |
S3 |
p. S21-
1 p.
|
artikel
|
| 35 |
IN8 THE BIOLOGY OF LOCALLY ADVANCED BREAST CANCER: INFLAMMATORY AND NON-INFLAMMATORY
|
Penault-Llorca, Frédérique
|
|
2013
|
22 |
S3 |
p. S20-S21
2 p.
|
artikel
|
| 36 |
OR130 META-ANALYSIS RESOLVES THE ROLE OF COMBINATION VERSUS SEQUENTIAL CHEMOTHERAPY FOR METASTATIC BREAST CANCER
|
Dear, Rachel
|
|
2013
|
22 |
S3 |
p. S63-
1 p.
|
artikel
|
| 37 |
OR130 META-ANALYSIS RESOLVES THE ROLE OF COMBINATION VERSUS SEQUENTIAL CHEMOTHERAPY FOR METASTATIC BREAST CANCER
|
Dear, Rachel
|
|
2013
|
22 |
S3 |
p. S32-S33
2 p.
|
artikel
|
| 38 |
OR39 OVERALL SURVIVAL AND SEQUENTIAL TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS – OUTCOME DATA FROM THE TMK REGISTRY GROUP
|
Marschner, Norbert
|
|
2013
|
22 |
S3 |
p. S32-
1 p.
|
artikel
|
| 39 |
OR26 THE CHALLENGES IN OPTIMISING CARE IN PATIENTS WITH ADVANCED BREAST CANCER: RESULTS OF AN INTERNATIONAL SURVEY
|
McCutcheon, Susan
|
|
2013
|
22 |
S3 |
p. S27-
1 p.
|
artikel
|
| 40 |
OR112 WHAT WE KNOW ABOUT PRIMARY METASTATIC BREAST CANCER: PATHOLOGICAL CHARACTERISTICS AND OUTCOME OVER A 10-YEAR PERIOD
|
Barinoff, Jana
|
|
2013
|
22 |
S3 |
p. S57-S58
2 p.
|
artikel
|
| 41 |
PO54 ACTIVITY AND DURATION OF CHEMOTHERAPY IN DIFFERENT BIOLOGIC SUBTYPES (BS) IN METASTATIC BREAST CANCER (MBC) PATIENTS
|
Lambertini, Matteo
|
|
2013
|
22 |
S3 |
p. S38-
1 p.
|
artikel
|
| 42 |
PO89 ADVANCED BREAST CANCER IN ETHIOPIA: CHARACTERISTICS AND FOLLOW-UP OF 148 PATIENTS WITH STAGE 4 DISEASE
|
Kantelhardt, Eva Johanna
|
|
2013
|
22 |
S3 |
p. S50-
1 p.
|
artikel
|
| 43 |
PO37 ADVANCED BREAST CANCER: LIVING IN THE MOMENT. NEVER GIVE UP; EVEN TOWARD THE END OF LIFE, A TINY FLAME OF CANDLE CAN GIVE STILL WARMTH
|
Lin, Gloria Wei-Chieh
|
|
2013
|
22 |
S3 |
p. S31-
1 p.
|
artikel
|
| 44 |
PO38 A HEALTHY WALK WITH STICKS IN THE MIDST OF NATURE
|
Fishwick, Julia Lynn
|
|
2013
|
22 |
S3 |
p. S31-
1 p.
|
artikel
|
| 45 |
PO66 ALL-ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IS EFFECTIVE AND SAFE FOR METASTATIC BREAST CANCER PATIENTS
|
Suzuki, Masahiko
|
|
2013
|
22 |
S3 |
p. S42-
1 p.
|
artikel
|
| 46 |
PO52 ARE POSTCHEMOTHERAPY TARGET VOLUME ADEQUATE AS BOOST VOLUME FOR CONSERVED BREAST IN LOCALLY ADVANCED BREAST CANCER?
|
Agrawal, Sushma
|
|
2013
|
22 |
S3 |
p. S37-
1 p.
|
artikel
|
| 47 |
PO83 ASSESSING ACUTE THROMBOPHLEBITIS DUE TO INTRAVENOUS VINORELBINE CHEMOTHERAPY IN METASTATIC BREAST CANCER (MBC) PATIENTS AT THE UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE (UHNS)
|
Gilani, S.
|
|
2013
|
22 |
S3 |
p. S48-
1 p.
|
artikel
|
| 48 |
PO44 AUDIT OF THE INVESTIGATION AND MANAGEMENT OF LOCO-REGIONAL BREAST CANCER RECURRENCES IN A UK DISTRICT GENERAL HOSPITAL
|
Elvy, Alice
|
|
2013
|
22 |
S3 |
p. S34-S35
2 p.
|
artikel
|
| 49 |
PO105 CHANGES IN ACTIVITIES AND PARTICIPATION RESULTING IN DISABILITY ASSOCIATED WITH METASTATIC BREAST CANCER
|
Potter, Ann Marie
|
|
2013
|
22 |
S3 |
p. S55-
1 p.
|
artikel
|
| 50 |
PO85 CHARACTERISTICS AND PROGNOSIS OF HORMONE RECEPTOR POSITIVE AND HER2 NEGATIVE RECURRENT BREAST CANCER PATIENTS RECEIVING POSTOPERATIVE AROMATASE INHIBITOR
|
Mayumi, Ishida
|
|
2013
|
22 |
S3 |
p. S48-S49
2 p.
|
artikel
|
| 51 |
PO67 CLINICAL BENEFIT OF ETHINYLESTRADIOL AS A SALVAGE ENDOCRINE THERAPY FOR THE HEAVILY PRETREATED METASTATIC BREAST CANCER
|
Iwase, Hirotaka
|
|
2013
|
22 |
S3 |
p. S43-
1 p.
|
artikel
|
| 52 |
PO70 CLINICAL BENEFIT OF FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER ACCORDING TO PRIOR THERAPY
|
De Angelis, Carmine
|
|
2013
|
22 |
S3 |
p. S44-
1 p.
|
artikel
|
| 53 |
PO72 CLINICAL SAFETY AND EFFICACY OF LONG-TERM USE OF ZOLEDRONIC ACID HYDRATE FOR BREAST CANCER BONE METASTASIS
|
Osako, Tomofumi
|
|
2013
|
22 |
S3 |
p. S44-S45
2 p.
|
artikel
|
| 54 |
PO53 CLINICAL TARGET VOLUME IN CONSERVED BREAST IN LOCALLY ADVANCED BREAST CANCER
|
Agrawal, Sushma
|
|
2013
|
22 |
S3 |
p. S37-
1 p.
|
artikel
|
| 55 |
PO82 CLINICOPATHOLOGICAL ANALYSIS OF THE RISK FACTORS OF DISEASE PROGRESSION IN HER2 POSITIVE BREAST CANCER PATIENTS
|
Huszno, Joanna
|
|
2013
|
22 |
S3 |
p. S47-
1 p.
|
artikel
|
| 56 |
PO76 CLINICOPATHOLOGICAL FEATURES AND SURVIVAL AFTER RECURRENCE IN BREAST CANCER PATIENTS WITH EARLY AND LATE RECURRENCE AFTER ADJUVANT CHEMOTHERAPY
|
Son, Byung Ho
|
|
2013
|
22 |
S3 |
p. S46-
1 p.
|
artikel
|
| 57 |
PO57 COMPARISON OF DOCETAXEL PLUS TRASTUZUMAB (DT) AND VINORELBINE PLUS TRASTUZUMAB (VT) AS FIRST-LINE THERAPY OF ANTHRACYCLINE PRE-TREATED METASTATIC OR LOCALLY ADVANCED HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE BREAST CANCER (A SUB-GROUP ANALYSIS OF THE HERNATA STUDY)
|
Langkjer, Sven T.
|
|
2013
|
22 |
S3 |
p. S39-
1 p.
|
artikel
|
| 58 |
PO64 COMPARISON OF FULVESTRANT VERSUS TAMOXIFEN FOR TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
|
Singh, Charu
|
|
2013
|
22 |
S3 |
p. S42-
1 p.
|
artikel
|
| 59 |
PO28 DEFINING THE UNIQUE AND PERSISTENT NEEDS OF YOUNG WOMEN IN THE U.S. LIVING WITH METASTATIC BREAST CANCER THROUGH A MULTI-PHASED NEEDS ASSESSMENT
|
Hanson, Arin
|
|
2013
|
22 |
S3 |
p. S28-
1 p.
|
artikel
|
| 60 |
PO62 DIFFERENT PATTERNS OF TREATMENT WITH ALBUMIN-BOUND PACLITAXEL (NAB-PACLITAXEL) FOR TARGETED CHEMOTHERAPY IN METASTATIC BREAST CANCER: A MULTICENTER ITALIAN EXPERIENCE ON 125 WOMEN
|
Palumbo, Raffaella
|
|
2013
|
22 |
S3 |
p. S41-
1 p.
|
artikel
|
| 61 |
PO116 DISCORDANCE IN TRIPLE-RECEPTOR STATUS BETWEEN PRIMARY AND RECURRENT BREAST CANCER
|
Matsumoto, Akiko
|
|
2013
|
22 |
S3 |
p. S59-
1 p.
|
artikel
|
| 62 |
PO113 DISCORDANCE OF HORMONE RECEPTOR AND HER2 STATUS BETWEEN PRIMARY AND RECURRENT BREAST CANCER: NEW TREATMENT STRATEGY FOR PREDICTING OUTCOME OF PATIENTS WITH BREAST CANCER
|
Shiino, Sho
|
|
2013
|
22 |
S3 |
p. S58-
1 p.
|
artikel
|
| 63 |
PO77 DISEASE CHARACTERISTICS IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS ACHIEVING COMPLETE REMISSION DURING TRASTUZUMAB THERAPY
|
Susnjar, Snezana
|
|
2013
|
22 |
S3 |
p. S46-
1 p.
|
artikel
|
| 64 |
PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6
|
de Boer, Richard
|
|
2013
|
22 |
S3 |
p. S40-
1 p.
|
artikel
|
| 65 |
PO58 EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS PLUS LETROZOLE IN ER+ HER2− METASTATIC BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-4
|
Azevedo, Sergio
|
|
2013
|
22 |
S3 |
p. S39-S40
2 p.
|
artikel
|
| 66 |
PO81 ELECTROCHEMOTHERAPY OF SKIN BREAST CANCER METASTASES
|
Oom, Rodrigo
|
|
2013
|
22 |
S3 |
p. S47-
1 p.
|
artikel
|
| 67 |
PO69 ERIBULIN IN PRACTICE, REVIEW OF 70 CASES FROM SINGLE INSTITUTE AND COMPARISON WITH JAPAN PHASE 2 STUDY
|
Watanabe, Junichiro
|
|
2013
|
22 |
S3 |
p. S43-S44
2 p.
|
artikel
|
| 68 |
PO115 EXPRESSION OF ANDROGEN RECEPTOR IN LOCALLY ADVANCED BREAST CANCER WITH SPECIAL RELATION TO VARIOUS MOLECULAR PHENOTYPES, CLINICOPATHOLOGICAL FACTORS AND RESPONSE TO ANTERIOR CHEMOTHERAPY IN INDIAN WOMEN
|
Anand, Akshay
|
|
2013
|
22 |
S3 |
p. S58-S59
2 p.
|
artikel
|
| 69 |
PO106 EXTENDED STABILITY STUDIES OF ANTICANCER DRUGS CAN IMPROVE THE ACCESS OF PATIENTS TO INNOVATIVE TREATMENTS. EXAMPLE OF ERIBULIN IN ADVANCED/METASTATIC BREAST CANCER
|
Astier, Alain
|
|
2013
|
22 |
S3 |
p. S55-S56
2 p.
|
artikel
|
| 70 |
PO120 FACTORS AFFECTING CHANGES IN IMMUNOHISTOCHEMISTRY PHENOTYPE OF BREAST CANCER
|
Aseyev, Olexiy
|
|
2013
|
22 |
S3 |
p. S60-
1 p.
|
artikel
|
| 71 |
PO34 FUNDING PRIORITIES FOR CANCER RESEARCH IN USA – AN ADVOCACY INITIATIVE TO GAUGE PERCEPTION OF METASTATIC BREAST CANCER RESEARCH AND FUNDING AMONGST CANCER RESEARCHERS IN THE USA
|
Santhanam, Arti
|
|
2013
|
22 |
S3 |
p. S30-
1 p.
|
artikel
|
| 72 |
PO60 GOOD RESULTS OF INTENSIVE SYSTEMIC TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
|
Niwinska, Anna
|
|
2013
|
22 |
S3 |
p. S40-
1 p.
|
artikel
|
| 73 |
PO32 HOW DO WOMEN WITH METASTATIC BREAST CANCER VIEW PALLIATIVE CARE? A QUALITATIVE STUDY USING A GROUNDED THEORY APPROACH TO ENABLE THE VIEWS OF WOMEN TO BE SOUGHT
|
Beaumont, Tara
|
|
2013
|
22 |
S3 |
p. S29-
1 p.
|
artikel
|
| 74 |
PO119 IMMUNE REACTIVITY IN PATIENTS WITH BREAST CANCER ASSOCIATED WITH TYPE 2 DIABETES MELLITUS
|
Botnariuc, Natalia
|
|
2013
|
22 |
S3 |
p. S60-
1 p.
|
artikel
|
| 75 |
PO63 IMPACT OF TREATMENT WITH LAPATINIB IN SYSTEMIC ADVANCED BREAST CARCINOMA
|
Behera, Manoj
|
|
2013
|
22 |
S3 |
p. S41-S42
2 p.
|
artikel
|
| 76 |
PO117 IMPAIRMENT OF IFN GAMMA PRODUCTION AND NK CELL CYTOTOXICITY OF ADVANCED BREAST CANCER PATIENTS
|
Radenkovic, Sandra
|
|
2013
|
22 |
S3 |
p. S59-
1 p.
|
artikel
|
| 77 |
PO103 IMPROVING PALLIATIVE CARE IN CLINICAL ROUTINE: IN-HOUSE TRAINING OF PALLIATIVE MEDICINE AND ITS EFFECTS AND EVALUATION IN A BREAST AND GYNECOLOGICAL CENTER OF A CCC
|
Wuerstlein, Rachel
|
|
2013
|
22 |
S3 |
p. S54-S55
2 p.
|
artikel
|
| 78 |
PO121 INCREASED RELAPSE RATIOS IN NODE-POSITIVE BREAST CANCER PATIENTS WITH METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM
|
Buyukhatipoglu, Hakan
|
|
2013
|
22 |
S3 |
p. S60-S61
2 p.
|
artikel
|
| 79 |
PO36 INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION: PATIENT INFORMATION AND SUPPORT, RESEARCH COLLABORATION AND IBC BIOBANK
|
Mason, Ginny
|
|
2013
|
22 |
S3 |
p. S31-
1 p.
|
artikel
|
| 80 |
PO125 INFLUENCE OF HER2 STATUS ON METASTATIC PATTERN IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT TAMOXIFEN ONLY
|
Spasojevic, Ivana Bozovic
|
|
2013
|
22 |
S3 |
p. S62-
1 p.
|
artikel
|
| 81 |
PO75 IS THE BREAST CANCER GRADED PROGNOSTIC ASSESSMENT TOOL VALID IN SCOTTISH PATIENTS WITH SECONDARY BRAIN METASTASES?
|
Wells, L.A.R.
|
|
2013
|
22 |
S3 |
p. S45-S46
2 p.
|
artikel
|
| 82 |
PO88 LOCALLY ADVANCED BREAST CANCER IN ALBANIAN WOMEN
|
Kozma, Elvisa
|
|
2013
|
22 |
S3 |
p. S49-S50
2 p.
|
artikel
|
| 83 |
PO100 LONG-TERM BONE MANAGEMENT BY BISPHOSPHONATE IN METASTATIC BREAST CANCER PATIENTS
|
Watanabe, Junichiro
|
|
2013
|
22 |
S3 |
p. S53-
1 p.
|
artikel
|
| 84 |
PO101 MANAGEMENT OF PERIPHERAL NEUROPATHY INDUCED BY NAB-PTX THERAPY FOR BREAST CANCER
|
Ohno, Tsuyoshi
|
|
2013
|
22 |
S3 |
p. S53-S54
2 p.
|
artikel
|
| 85 |
PO29 METASTATIC BREAST CANCER IN CANADA: THE LIVED EXPERIENCE OF PATIENTS AND CAREGIVERS PRESENTED BY THE CANADIAN BREAST CANCER NETWORK
|
Chari, Niya
|
|
2013
|
22 |
S3 |
p. S28-
1 p.
|
artikel
|
| 86 |
PO80 NEUTROPENIA MAY BE A PREDICTION MARKER OF THERAPEUTIC EFFECT IN METASTATIC BREAST CANCER PATIENTS TREATED WITH ERIBULIN
|
Yoshimura, Yuri
|
|
2013
|
22 |
S3 |
p. S47-
1 p.
|
artikel
|
| 87 |
PO74 NEW TRENDS IN THE SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
|
El Saghir, Nagi
|
|
2013
|
22 |
S3 |
p. S45-
1 p.
|
artikel
|
| 88 |
PO61 ORAL VINORELBINE (VNR) AND CAPECITABINE (CAP): AN ACCEPTABLE AND EFFECTIVE COMBINATION CHEMOTHERAPY FOR EARLY METASTATIC BREAST CANCER (MBC)
|
Hogg, Martin
|
|
2013
|
22 |
S3 |
p. S41-
1 p.
|
artikel
|
| 89 |
PO102 PACLITAXEL INDUCED CIPN – CAN IT BE CONTROLLED?
|
Roy, Rakesh
|
|
2013
|
22 |
S3 |
p. S54-
1 p.
|
artikel
|
| 90 |
PO31 PALLIATIVE CARE AND METASTATIC BREAST CANCER: INVOLVEMENT OF A COMMUNITY PALLIATIVE CARE SPECIALIST NURSING TEAM
|
Leadbeater, Maria
|
|
2013
|
22 |
S3 |
p. S29-
1 p.
|
artikel
|
| 91 |
PO104 PATIENTS WITH DISCORDANCE IN ESTROGEN RECEPTOR BETWEEN PRIMARY BREAST CANCERS AND RECURRENT TUMORS HAVE POOR OUTCOMES
|
Akiyoshi, Sayuri
|
|
2013
|
22 |
S3 |
p. S55-
1 p.
|
artikel
|
| 92 |
PO122 PREDICTIVE FACTOR OF LATE RECURRENCES IN BREAST CANCER PATIENTS
|
Jinno, Hiromitsu
|
|
2013
|
22 |
S3 |
p. S61-
1 p.
|
artikel
|
| 93 |
PO86 PREDICTIVE MARKERS OF CLINICAL OUTCOME FOR BREAST CANCER PATIENTS TREATED IN PHASE 1 TRIALS: NATIONAL CANCER CENTER HOSPITAL EXPERIENCE
|
Nagayama, Aiko
|
|
2013
|
22 |
S3 |
p. S49-
1 p.
|
artikel
|
| 94 |
PO87 PROGNOSTIC FACTORS PREDICTING SURVIVAL AFTER FIRST RECURRENCE IN PATIENTS WITH METASTATIC BREAST CANCER
|
Hikichi, Masahiro
|
|
2013
|
22 |
S3 |
p. S49-
1 p.
|
artikel
|
| 95 |
PO79 PROLONGED SURVIVAL AFTER BREAST CANCER BRAIN METASTASES (BCBM): WHO HAS A CHANCE?
|
Tomasevic, Zorica
|
|
2013
|
22 |
S3 |
p. S46-S47
2 p.
|
artikel
|
| 96 |
PO46 PULMONARY RESECTION FOR LUNG OLIGOMETASTATIC DISEASE IN METASTATIC BREAST CANCER
|
Kochi, Mariko
|
|
2013
|
22 |
S3 |
p. S35-
1 p.
|
artikel
|
| 97 |
PO43 ROLE OF BREAST SURGERY ON SURVIVAL OF PATIENTS WITH PRIMARY ADVANCED BREAST CANCER
|
Liubota, Iryna
|
|
2013
|
22 |
S3 |
p. S34-
1 p.
|
artikel
|
| 98 |
PO108 SAFETY AND EFFICACY OF BRACHIUM IMPLANTED CENTRAL VENOUS ACCESS PORT FOR METASTATIC BREAST CANCER PATIENTS
|
Fujisawa, Tomomi
|
|
2013
|
22 |
S3 |
p. S56-
1 p.
|
artikel
|
| 99 |
PO71 SAFETY PROFILE AND TOLERABILITY OF TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY
|
Tancredi, Richard
|
|
2013
|
22 |
S3 |
p. S44-
1 p.
|
artikel
|
| 100 |
Poster Session
|
|
|
2013
|
22 |
S3 |
p. S17-S18
2 p.
|
artikel
|
| 101 |
PO107 STUDY OF HEALTH RESOURCE UTILISATION IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER (SHRUB) – A PROSPECTIVE DATA COLLECTION STUDY IN PROGRESS
|
Abraham, Jacinta
|
|
2013
|
22 |
S3 |
p. S56-
1 p.
|
artikel
|
| 102 |
PO42 SURGICAL MANAGEMENT OF PRIMARY TUMOR IN NEWLY DIAGNOSED METASTATIC BREAST CANCER PATIENTS – A SYSTEMATIC REVIEW OF THE LITERATURE
|
Ades, Felipe
|
|
2013
|
22 |
S3 |
p. S34-
1 p.
|
artikel
|
| 103 |
PO45 SURGICAL RESECTION OF THE PRIMARY TUMOR MAY IMPROVE SURVIVAL IN PATIENTS WITH STAGE IV BREAST CANCER
|
Higaki, Kenji
|
|
2013
|
22 |
S3 |
p. S35-
1 p.
|
artikel
|
| 104 |
PO30 SURVEYING YOUNG WOMEN WITH METASTATIC BREAST CANCER TO CREATE INTERVENTIONS WITH IMPACT
|
Rowe, Jean
|
|
2013
|
22 |
S3 |
p. S28-S29
2 p.
|
artikel
|
| 105 |
PO33 SUSAN G. KOMEN® INVESTMENT IN METASTATIC BREAST CANCER (MBC)
|
Durham, Karen S.
|
|
2013
|
22 |
S3 |
p. S30-
1 p.
|
artikel
|
| 106 |
PO55 THE COMBINATION CHEMOTHERAPY OF GEMCITABINE AND VINORELBINE IN HER2-NEGATIVE PATIENTS WITH TAXANE-PRETREATED METASTATIC BREAST CANCER: A PHASE II STUDY OF KINKI MULTIDISCIPLINARY BREAST ONCOLOGY GROUP (KMBOG) 1015 (UMIN000004839)
|
Yamamura, Jun
|
|
2013
|
22 |
S3 |
p. S38-
1 p.
|
artikel
|
| 107 |
PO65 THE COMPARISON OF METHOTREXATE AND LIPOSOMAL CYTARABINE IN THE INTRATHECAL TREATMENT OF PATIENTS WITH BREAST CANCER AND LEPTOMENINGEAL METASTASIS
|
Niwinska, Anna
|
|
2013
|
22 |
S3 |
p. S42-
1 p.
|
artikel
|
| 108 |
PO124 THE INFLUENCE OF HER2 STATUS ON LOCALIZATION OF THE FIRST RELAPSE SITE IN YOUNG HR-POSITIVE BREAST CANCER PATIENTS TREATED WITH ADJUVANT OVARIAN ABLATION
|
Milovic-Kovacevic, Marijana
|
|
2013
|
22 |
S3 |
p. S62-
1 p.
|
artikel
|
| 109 |
PO123 THYMIDYLATE SYNTHASE EXPRESSION AS A SIGNIFICANT PREDICTIVE FACTOR IN METASTATIC BREAST CANCER
|
Seki, Hirohito
|
|
2013
|
22 |
S3 |
p. S61-S62
2 p.
|
artikel
|
| 110 |
PO68 TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
|
Lynge, M.
|
|
2013
|
22 |
S3 |
p. S43-
1 p.
|
artikel
|
| 111 |
PO56 TRIPLE NEGATIVE AND HORMONE-NEGATIVE/HER2-POSITIVE BREAST CANCER: WHICH THE WORST FOR WOMEN WITH METASTATIC DISEASE? A MONO-INSTITUTIONAL RETROSPECTIVE ANALYSIS ON 460 PATIENTS
|
Palumbo, Raffaella
|
|
2013
|
22 |
S3 |
p. S39-
1 p.
|
artikel
|
| 112 |
PO109 USE OF WHOLE BODY MRI IN BREAST CANCER: A RETROSPECTIVE ANALYSIS OF WB-MRIS WITHIN A 12 MONTH PERIOD IN A CANCER CENTRE
|
Trivedi, Bhavi
|
|
2013
|
22 |
S3 |
p. S56-S57
2 p.
|
artikel
|
| 113 |
PO47 USING LOCAL FLAPS FOR COVERAGE OF DEFECTS AFTER EXCISION OF ADVANCED MALIGNANT BREAST LESIONS
|
Alhussini, Mahmoud
|
|
2013
|
22 |
S3 |
p. S35-
1 p.
|
artikel
|
| 114 |
PO84 VISUALIZING TREATMENT AND OUTCOMES IN METASTATIC BREAST CANCER
|
Rocque, Gabrielle
|
|
2013
|
22 |
S3 |
p. S48-
1 p.
|
artikel
|
| 115 |
PO35 YSC RESEARCH THINK TANK: DETERMINING RESEARCH PRIORITIES FOR YOUNG WOMEN WITH METASTATIC BREAST CANCER
|
Rowe, Jean
|
|
2013
|
22 |
S3 |
p. S30-S31
2 p.
|
artikel
|
| 116 |
PR97 ADVANCED BURKITT'S LYMPHOMA OF THE BREAST IN SUB-SAHARIAN AFRICA
|
Blaise, Nkegoum
|
|
2013
|
22 |
S3 |
p. S52-
1 p.
|
artikel
|
| 117 |
PR126 A RESVERATROL ANALOGUE RHAPONTIGENIN REGULATES ER STRESS RESPONSE IN MCF-7 CELLS
|
Lee, JinSun
|
|
2013
|
22 |
S3 |
p. S63-
1 p.
|
artikel
|
| 118 |
PR98 BREAST CANCER AND HYPOTHYROIDISM IN IRAN
|
Adili, Ali
|
|
2013
|
22 |
S3 |
p. S52-S53
2 p.
|
artikel
|
| 119 |
PR96 BREAST CANCER AND LUNG METASTASES: WHICH WOMEN ARE AT RISK?
|
Kahharov, Alisher
|
|
2013
|
22 |
S3 |
p. S52-
1 p.
|
artikel
|
| 120 |
PR49 CHEST WALL RECONSTRUCTION USING EXTERNAL OBLIQUE MYOCUTANEOUS RETAIL IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER: 3 CASES REPORT
|
Chagas, Eduardo
|
|
2013
|
22 |
S3 |
p. S36-
1 p.
|
artikel
|
| 121 |
PR94 CLINICAL FEATURES AND OUTCOMES OF REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME FOLLOWING BEVACIZUMAB TREATMENT
|
Iwamoto, Mitsuhiko
|
|
2013
|
22 |
S3 |
p. S51-S52
2 p.
|
artikel
|
| 122 |
PR93 CLINICOPATHOLOGICAL EVALUATION OF BRAIN METASTASES RECURRENCE IN METASTATIC HER2+ BREAST CANCER PATIENTS
|
Cudós, Ariadna Gasol
|
|
2013
|
22 |
S3 |
p. S51-
1 p.
|
artikel
|
| 123 |
PR48 CLOSED SURGICAL MARGINS WERE STILL PREDICTOR OF IBTR ON LABCS AFTER PRIMARY SYSTEMIC CHEMOTHERAPY AND MASTECTOMY
|
Azhar, Yohana
|
|
2013
|
22 |
S3 |
p. S36-
1 p.
|
artikel
|
| 124 |
PR95 DISEASE FREE PERIOD AND SURVIVAL AFTER INITIAL TREATMENT OF HER2 NEGATIVE LOCALLY ADVANCED BREAST CANCER
|
Han, Sehwan
|
|
2013
|
22 |
S3 |
p. S52-
1 p.
|
artikel
|
| 125 |
PR127 EFFECT OF IFN ALPHA AND IFN GAMMA ON PROLIFERATION AND RECEPTOR PROFILE LINE OF BREAST AND COLON CANCER CELLS
|
Demianenko, Dmytro
|
|
2013
|
22 |
S3 |
p. S63-
1 p.
|
artikel
|
| 126 |
PR73 ELECTROCHEMOTHERAPY: AN EFFECTIVE TREATMENT FOR INTRACTABLE CUTANOUS LESIONS SECONDARY TO BREAST CANCER
|
Nizar, Bafiq
|
|
2013
|
22 |
S3 |
p. S45-
1 p.
|
artikel
|
| 127 |
PR90 ETOPOSIDE PLUS CISPLATIN COMBINATION THERAPY IN PATIENTS WITH ADVANCED BREAST CANCER PRETREATED WITH ANTHRACYCLINES
|
Ahn, Byong Hyon
|
|
2013
|
22 |
S3 |
p. S50-
1 p.
|
artikel
|
| 128 |
PR114 EXPRESSION OF THE RE, RPG, KI-67 AND HER-2 IN LOCALLY ADVANCED BREAST CANCER AND CORRELATION WITH IN VIVO RESISTANCE WITH TAMOXIFEN AND LETROZOLE
|
Chagas, Eduardo
|
|
2013
|
22 |
S3 |
p. S58-
1 p.
|
artikel
|
| 129 |
PR110 18FDG-PET-CT AND STAGE III BREAST CANCER – SINGLE INSTITUTION EXPERIENCE
|
Yordanov, Kaloyan
|
|
2013
|
22 |
S3 |
p. S57-
1 p.
|
artikel
|
| 130 |
PR50 HEPATIC METASTASECTOMY IN BREAST CANCER LIVER METASTASES: ONE CENTER EXPERIENCE
|
Fernandes, Ana Catarina
|
|
2013
|
22 |
S3 |
p. S36-
1 p.
|
artikel
|
| 131 |
Programme
|
|
|
2013
|
22 |
S3 |
p. S11-S14
4 p.
|
artikel
|
| 132 |
PR51 PATTERNS OF FAILURE IN BREAST CANCER PATIENTS TREATED WITH MASTECTOMY WITHOUT RADIOTHERAPY
|
Mehmood, Tahir
|
|
2013
|
22 |
S3 |
p. S37-
1 p.
|
artikel
|
| 133 |
PR129 PATTERNS OF THE IMMUNOHISTOCHEMICAL DETECTION OF HORMONE RECEPTOR EXPRESSION IN PRIMARY VERSUS PAIRED METASTATIC LESION OF BREAST CANCER
|
Park, Heeseung
|
|
2013
|
22 |
S3 |
p. S63-
1 p.
|
artikel
|
| 134 |
PR92 POSSIBILITY OF BEVACIZUMAB/PACLITAXEL THERAPY FOR ADVANCED RECURRENT BREAST CANCER PREVIOUSLY TREATED WITH PACLITAXEL
|
Hasegawa, Yoshie
|
|
2013
|
22 |
S3 |
p. S51-
1 p.
|
artikel
|
| 135 |
PR99 QUALITY OF LIFE (QOL) IN METASTATIC BREAST CANCER PATIENTS WITH MAINTENANCE PACLITAXEL PLUS GEMCITABINE (PG) CHEMOTHERAPY: RESULTS FROM PHASE III, MULTICENTER, RANDOMIZED TRIAL OF MAINTENANCE CHEMOTHERAPY VERSUS OBSERVATION (KCSG-BR07-02)
|
Park, Yeon Hee
|
|
2013
|
22 |
S3 |
p. S53-
1 p.
|
artikel
|
| 136 |
PR118 SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER
|
Todorovic-Rakovic, Natasa
|
|
2013
|
22 |
S3 |
p. S59-S60
2 p.
|
artikel
|
| 137 |
PR111 TIME FACTOR FOR BREAST CANCER METASTASES DYNAMIC
|
Nowara, Elzbieta
|
|
2013
|
22 |
S3 |
p. S57-
1 p.
|
artikel
|
| 138 |
PR91 TOLERABILITY OF BEVACIZUMAB IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SINGLE INSTITUTION EXPERIENCE
|
Stamatovic, Ljiljana
|
|
2013
|
22 |
S3 |
p. S50-S51
2 p.
|
artikel
|
| 139 |
Sponsors (as of August 2013)
|
|
|
2013
|
22 |
S3 |
p. S5-
1 p.
|
artikel
|
| 140 |
Welcome
|
|
|
2013
|
22 |
S3 |
p. S1-
1 p.
|
artikel
|
Tijdschrift beschrijving